Q2 2026 transaction volume remained steady at 170 deals, roughly in line with 177 in Q1 2026 and 187 in Q2 2025, underscoring the selective posture that has defined the recent dealmaking environment. Investor discipline has kept a cohort on the sidelines, reserving participation for A-tier assets with a higher probability of closing. Suppressed PE exit activity remains a notable contributor to muted volume, though a robust pipeline of processes could drive an uptick in Q3 and Q4.
While the quarter featured notable exits, a significant share of platforms with constrained premium exit optionality remain held by funds. Certain sectors, pockets of PPM, reflect a “good house in a bad neighborhood” dynamic, where sector headwinds or misaligned valuation expectations suppress otherwise attractive assets.
Thematically, investors continue to prioritize assets with resilient revenue profiles, proven organic growth models, asset-light operations, and experienced management teams across fragmented markets. A growing cohort is simultaneously seeking cash-pay, outsourced, and B2B exposure to diversify from reimbursement risk. HCIT and tech-enabled services, facility-based services, and pharma commercialization saw notable platform activity, while strategic add-ons in multisite provider services remained resilient.
To print and download the full Q2 2026 Market Update report, please click below…
